Related Experiment Video
Updated: Aug 24, 2026

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
Published on: August 19, 2025
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
Martin Noël1, Claude Gagné, Jean Bergeron
1Centre de Recherche Clinique, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Hôpital Laval, Ste-Foy, Canada. martin.noel@crhl.ulaval.ca
Insights
High-dose simvastatin, a HMG-CoA reductase inhibitor, led to vitiligo regression in a patient. This suggests statins may modulate immune responses beneficial for autoimmune conditions like vitiligo.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- HMG-CoA reductase inhibitors (statins) are widely prescribed for hyperlipidemia and cardiovascular disease prevention.
- Statins possess known immunosuppressive properties, with applications in organ transplantation.
- Vitiligo is a chronic autoimmune condition characterized by depigmentation of the skin.
Purpose of the Study:
- To report an unusual case of vitiligo regression in a patient treated with high-dose simvastatin.
- To explore the potential role of statins as immunomodulators in autoimmune dermatological conditions.
Main Methods:
- Case report detailing a patient receiving high-dose simvastatin therapy.
- Observation and documentation of vitiligo changes during simvastatin treatment.
Main Results:
- Significant regression of vitiligo was observed in the patient during high-dose simvastatin treatment.
- The observed effect suggests a potential link between simvastatin and vitiligo repigmentation.
Conclusions:
- This case supports the hypothesis that immune dysregulation contributes to vitiligo pathogenesis.
- Statins may act as immunomodulators, offering potential therapeutic benefits beyond cardiovascular health, including in vitiligo.
- Further research into statins as a treatment for vitiligo is warranted.
Background:
HMG-CoA reductase inhibitors (statins) are commonly used in medicine to control blood lipid disorder. Large clinical trials have demonstrated that statins greatly reduces cardiovascular-related morbidity and mortality in patients with and without coronary artery disease. Also, the use of HMG-CoA reductase inhibitors has been reported to have immunosuppressive effects.
Case Presentation:
We describe an unusual case of regression of vitiligo in a patient treated with high dose simvastatin. The relation between simvastatin and regression of vitiligo in this case report may be related to the autoimmune pathophysiology of the disease.
Conclusion:
This unexpected beneficial impact provides another scientific credence to the hypothesis that immune mechanisms play a role in the development of vitiligo and that the use of statins as immuno-modulator could be of use not only for treatment relative to organ transplant but in other pathologies such as vitiligo.
Related Concept Videos
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Pleiotropy
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pharmacogenomics: Identification of New Drug Targets
Inhibitors of Viral Protein Synthesis
Epistasis
